← All companies

BOLT

Bolt Biotherapeutics, Inc.

BOLT Nasdaq Pharmaceutical Preparations EDGAR ↗

$3.98

-0.01 -0.25%

Key statistics

from XBRL data in SEC filings

Market cap

$7.65M

Revenue (TTM)

$6.50M

Net income (TTM)

-$29.6M

EPS (TTM)

$-16.40

P/E ratio

—

Dividend yield

—

Free cash flow

-$39.9M

Cash

$11.6M

Total assets

$48.0M

Gross margin

—

52-week range

$3.75 – $7.20

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 11, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Exit or disposal costs; Other events Oct 2, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Delisting notice or listing-rule failure; Amended charter or bylaws Jun 6, 2025 8-K Other events Jun 4, 2025 8-K Shareholder vote results May 28, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Amended charter or bylaws Apr 16, 2025 10-K Fiscal year ended 2024-12-31 Mar 24, 2025 8-K Results of operations (earnings release) Mar 24, 2025 8-K Delisting notice or listing-rule failure Jan 3, 2025 8-K Director or officer change Dec 23, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Director or officer change Sep 4, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Delisting notice or listing-rule failure Jul 3, 2024 8-K Shareholder vote results Jun 14, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Completed an acquisition or disposition; Exit or disposal costs; Director or officer change May 14, 2024 10-K Fiscal year ended 2023-12-31 Mar 21, 2024 8-K Results of operations (earnings release) Mar 21, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023 10-Q Quarter ended 2023-06-30 Aug 7, 2023 8-K Results of operations (earnings release) Aug 7, 2023 8-K Shareholder vote results Jun 13, 2023 10-Q Quarter ended 2023-03-31 May 11, 2023 8-K Results of operations (earnings release) May 11, 2023 10-K Fiscal year ended 2022-12-31 Mar 29, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Mar 29, 2023